Pay in 4 interest-free payments of $6.78 Learn more
Ships within 48 hours · Estimated delivery Aug 6 - Aug 11
A number of studies have found that GLP-1 receptor agonists can 9: Reduce body weight and waist circumference Improve insulin resistance (measured by HOMA-IR) Lower fasting glucose and insulin levels These changes may contribute to improvements in ovulatory function and menstrual regularity, particularly in individuals with overweight or obesity
Tirzepatide is a novel glucose-dependent insulinotropic polypeptide (GIP) and glucagon-like peptide-1 (GLP-1) receptor agonist licensed in the UK for the treatment of type 2 diabetes mellitus (as Mounjaro) and for weight management in adults with obesity or overweight with weight-related comorbidities
It supports the regeneration of nerve cells, aids in the production of DNA, and contributes to the formation of red blood cells
At 1 mg/mL, you would need 12.5 units, easy to read and draw
Common side effects of GLP-1s are gastrointestinal issues, including nausea, vomiting, diarrhea, dehydration, and constipation
US$ 23.02
US$ 28.23
US$ 23.23
US$ 20.87
US$ 25.37
US$ 29.75
US$ 27.37
US$ 22.32
US$ 29.62
US$ 25.86
